Endothelial Cell News Volume 7.08 | Mar 14 2022

    0
    29






    2022-03-14 | ENDOCN 7.08


    Endothelial Cell News by STEMCELL Technologies
    Vol. 7.08 – 14 March, 2022
    TOP STORY

    Elucidating Mechanisms of Genetic Cross-Disease Associations at the PROCR Vascular Disease Locus

    Researchers demonstrated that PROCR-219Gly increased plasma levels of protein C through endothelial protein C receptor ectodomain shedding in endothelial cells, attenuating leukocyte-endothelial cell adhesion and vascular inflammation.
    [Nature Communications]

    Full Article

    Request your free copy of the 'Cell-Reprogramming Technology and Neuroscience' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    βIV-Spectrin as a Stalk Cell-Intrinsic Regulator of VEGF Signaling

    Based on proteomic profiling of angiogenic endothelial components, researchers reported βIV-spectrin, a non-erythrocytic cytoskeletal protein, as a critical regulator of sprouting angiogenesis.
    [Nature Communications]

    Full Article

    Integration of Vascular Progenitors into Functional Blood Vessels Represents a Distinct Mechanism of Vascular Growth

    Investigators demonstrated that secondary vascular field cells participated in vascular recovery after chemical ablation of vascular endothelial cells.
    [Developmental Cell]

    Full ArticleGraphical Abstract

    RTN4/Nogo-a-S1PR2 Negatively Regulates Angiogenesis and Secondary Neural Repair through Enhancing Vascular Autophagy in the Thalamus after Cerebral Cortical Infarction

    Researchers investigated the role of RTN4/Nogo-A in mediating macroautophagy/autophagy and angiogenesis in the thalamus following middle cerebral artery occlusion.
    [Autophagy]

    Abstract

    Intercellular Transfer of miR-200c-3p Impairs the Angiogenic Capacity of Cardiac Endothelial Cells

    Scientists reported that cardiac stress-induced differential microRNA content, with miR-200c-3p being one of the most enriched, in cardiomyocyte-derived extracellular vesicles mediated functional crosstalk with endothelial cells.
    [Molecular Therapy]

    AbstractGraphical Abstract

    The Suppressive Effects of Mer Inhibition on Inflammatory Responses in the Pathogenesis of LPS-Induced ALI/ARDS

    In human pulmonary aortic endothelial cells,lipopolysaccharide-induced decreased in the amounts of endothelial nitric oxide synthase, thrombomodulin, and vascular endothelial–cadherin, which was blocked by treatment with UNC2250.
    [Science Signaling]

    Abstract

    Bone Marrow-Independent Adventitial Macrophage Progenitor Cells Contribute to Angiogenesis

    Macrophage-derived VEGF activated CD34+ progenitor cells within the adventitial vasculogenic zone to differentiate into CD31+ endothelial cells.
    [Cell Death & Disease]

    Full Article

    Plasma Tie2 Trajectories Identify Vascular Response Criteria for VEGF Inhibitors across Advanced Biliary Tract, Colorectal and Ovarian Cancers

    Researchers investigated whether plasma Tie2 could predict response and progression cross-tumor for generic vascular endothelial growth factor inhibitors (VEGFi) treatment.
    [ESMO Open]

    Full Article

    HDAC11 Promotes Both NLRP3/Caspase-1/GSDMD and Caspase-3/GSDME Pathways Causing Pyroptosis via ERG in Vascular Endothelial Cells

    The authors investigated the role of histone deacetylase 11 (HDAC11) in vascular endothelial cell pyroptosis and its molecular mechanism.
    [Cell Death Discovery]

    Full Article

    Novel Indolic AMPK Modulators Induce Vasodilatation through Activation of the AMPK–eNOS–NO Pathway

    Scientists reported the identification of a novel adenosine monophosphate-activated protein kinase (AMPK) modulator, the indolic derivative IND6, which showed affinity for AMPKα1β1γ1, the primary AMPK isoform in human EA.Hy926 endothelial cells.
    [Scientific Reports]

    Full Article

    Subscribe to Science News for free weekly science newsletters.
    REVIEWS

    Role of Swiprosin-1/EFHD2 as a Biomarker in the Development of Chronic Diseases

    The aim of this review is to summarize and provide an overview of the role of swiprosin-1 in pathophysiological conditions of cancers, cardiovascular diseases, diabetic nephropathy, neuropsychiatric diseases, and in the process of inflammation, immune response, and inflammatory diseases.
    [Life Sciences]

    Abstract

    INDUSTRY AND POLICY NEWS

    Health Canada Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (Ranibizumab)

    Samsung Bioepis Co., Ltd. and Biogen Canada Inc. announced that Health Canada has approved BYOOVIZ™ a biosimilar referencing LUCENTIS® for the treatment of neovascular age-related macular degeneration; visual impairment due to diabetic macular edema.
    [Samsung Bioepis Co., Ltd.]

    Press Release

    FEATURED EVENT

    Sy-Stem 2022

    March 20 – March 25, 2022
    Vienna, Austria

    > See All Events

    JOB OPPORTUNITIES

    Flow Cytometry Assistant or Specialist – Flow Cytometry

    Babraham Institute – Cambridgeshire, England, United Kingdom

    Postdoctoral Fellow – Vascular Biology

    Johns Hopkins School of Medicine – Saint Petersburg, Florida, United States

    Postdoctoral Position – Cardiovascular Physiology

    The University of Tennessee Health Science Center – Memphis, Tennessee, United States

    Postdoctoral Scientist – Tissue Engineering, and Stem Cell Biology

    Yale University – New Haven, Connecticut, United States

    Postdoctoral Positions – Atherosclerosis

    Columbia University – New York, New York, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Endothelial Cell News Twitter